MWNA
AXNX

Marshall Wace North America’s Axonics, Inc. Common Stock AXNX Stock Holding History

Marshall Wace North America’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,476
Closed -$573K – 1837
2020
Q4 		$573K Buy
+11,476
New +$539K ﹤0.01% 1061

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Marshall Wace North America's AXNX Position: Q1 2021 in Review

Marshall Wace North America sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2021, closing a stake of 11,476 shares — an estimated $573K sold.

Marshall Wace North America first reported a position in AXNX in Q4 2020 and held it in 1 quarter. The position peaked at $573K in Q4 2020. 160 funds tracked by Wall St. Rank hold AXNX as of Q1 2021.

  • Marshall Wace North America reported no remaining Axonics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace North America sold 11,476 Axonics, Inc. Common Stock shares in Q1 2021, an estimated $573K.
  • Marshall Wace North America first reported a position in Axonics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Marshall Wace North America's Axonics, Inc. Common Stock position peaked at $573K in Q4 2020.
  • 160 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.